CereVasc: Funding, Investors & Team (Oct 2026)
CereVasc specializes in creating new, less invasive medical devices for treating patients with neurological conditions. The current standard treatment for these patients involves a risky neurosurgical procedure with a lower success rate compared to other similar interventions. The eShunt System has the potential to greatly enhance patient outcomes and reduce the overall cost of treating this serious condition.
CereVasc has raised $155M across 2 funding rounds on record, the most recent a Series C of $85.0M announced in Jun 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CereVasc Company Profile and Key Stats
Latest funding round on record: Jun 2026.
CereVasc Funding Rounds
CereVasc raised $70.0M in a Series B announced in May 2024.
2.1 years later, a Series C of $85.0M was announced in Jun 2026.
CereVasc Founders and Leadership Team
No contact details are on record for this team yet.
CereVasc Funding Compared to Other Biotechnology Startups
CereVasc's latest round of $85.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CereVasc in Biotechnology and Auburndale
Companies Similar to CereVasc
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
CereVasc Funding FAQs
What does CereVasc do?
CereVasc specializes in creating new, less invasive medical devices for treating patients with neurological conditions. The current standard treatment for these patients involves a risky neurosurgical procedure with a lower success rate compared to other similar interventions. The eShunt System has the potential to greatly enhance patient outcomes and reduce the overall cost of treating this serious condition.
How much funding has CereVasc raised?
CereVasc has raised $155M across 2 rounds on record. The most recent is a Series C of $85.0M announced in Jun 2026.
When did CereVasc last raise funding?
CereVasc's most recent funding round on record is a Series C of $85.0M, announced in Jun 2026.
Who founded CereVasc?
FundedIQ lists Adel Malek (Founder), Daniel Levangie (Founder) at CereVasc.
Where is CereVasc headquartered?
CereVasc is based in Auburndale, Massachusetts, United States.
How many employees does CereVasc have?
CereVasc is in the 11-50 employee band.
How does CereVasc's funding compare to other Biotechnology startups?
CereVasc's latest round of $85.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's CereVasc Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CereVasc is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.